Tango Therapeutics TNGX
NASDAQ TNGX
$23.24 -1.21 (-4.95%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Tango Therapeutics' Return on Capital Employed [ROCE] came in at -18.56% for Q2 2026, up 54.23 percentage points from -72.79% a year earlier and up 10.61 percentage points from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Tango Therapeutics' Return on Capital Employed [ROCE] was -33.13%, up 12.18 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a four-year change of -14.54 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -45.31% in FY2024 (-14.74 pp), -30.56% in FY2023 (-3.65 pp), -26.91% in FY2022 (-8.32 pp) and -18.59% in FY2021.
  • The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q1 2022.
  • Year-over-year, Return on Capital Employed [ROCE] has increased for three consecutive quarters, with an average year-over-year change of -0.84 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2026 (a gain of 54.23 percentage points), and the weakest in Q2 2025 (a drop of 34.95 percentage points).
  • Business Quant data shows TNGX's Return on Capital Employed [ROCE] at -29.17% (Q1 2026), -39.36% (Q4 2025) and -53.67% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Tango Therapeutics 3.91 Bn 2.02 Bn - -18.56%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.56%
Mar 31, 2026 -29.17%
Dec 31, 2025 -39.36%
Sep 30, 2025 -53.67%
Jun 30, 2025 -72.79%
Mar 31, 2025 -56.22%
Dec 31, 2024 -49.14%
Sep 30, 2024 -42.42%
Jun 30, 2024 -37.85%
Mar 31, 2024 -34.88%
Dec 31, 2023 -30.90%
Sep 30, 2023 -30.45%
Jun 30, 2023 -33.74%
Mar 31, 2023 -31.65%
Dec 31, 2022 -28.14%
Sep 30, 2022 -25.31%
Jun 30, 2022 -22.19%
Mar 31, 2022 -16.01%
Dec 31, 2021 -12.26%
Sep 30, 2021 -14.71%
API Access

Tango Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TNGX&period=max&api_key=YOUR_API_KEY